Active Ingredient History
Bibrocathol (trade names Noviform and Posiformin) is a well-established topical antiseptic for the treatment of acute eyelid diseases like blepharitis. Eye ointments containing 2 or 5 % bibrocathol and the excipients liquid paraffin, white soft paraffin, and lanolin have been marketed since 1967 for the treatment of eye irritation, chronic blepharitis, and uninfected corneal injuries. Reports of clinical experience with bibrocathol for inflammation of the edge of the palpebra exist since the beginning of the 20th century. Until recently, no controlled, randomized clinical studies according to the guidelines for Good Clinical Practice for Trials on Medical Products for Human Use (GCP) as defined by the International Conference on Harmonisation (ICH) have been performed with bibrocathol 2 % ointment, as these were not required for marketing authorization in the 1960s. A first double-blind, prospective, controlled, GCP-compliant clinical study was recently performed to assess the efficacy of bibrocathol 5 % (Noviform®) in acute blepharitis. It demonstrated superior efficacy of bibrocathol 5 % ointment as compared to an ointment vehicle (placebo) after 2 weeks of treatment as assessed by a combined measure of slit-lamp examination results and patients’ subjective complaints. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Bacterial Infections (Phase 4)
Bismuth (Phase 4)
Blepharitis (Phase 4)
Disease Eradication (Phase 1)
Dyspepsia (Phase 4)
Fatty Liver (Phase 2)
Gastritis (Phase 4)
Healthy Volunteers (Phase 1)
Helicobacter Infections (Phase 4)
Helicobacter pylori (Phase 4)
Insulin Resistance (Phase 2)
Intestinal Neoplasms (Phase 4)
Liver Diseases (Phase 2)
Medicine, Chinese Traditional (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 2)
Peptic Ulcer (Phase 4)
Signs and Symptoms (Phase 4)
Stomach Neoplasms (Phase 4)
Stomach Ulcer (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue